“We expect to keep narrowing our exposure beyond 2026.”

In context

“But it's taking too long there's too much variability in results among practices. We are actively address those factors. That's the overall picture of what is happening. I'll turn now to remediation. Our plan for improvement has four key elements. First and foremost, we are improving the implementation and consistency of our clinical model, which is anchored in primary care and supported by wraparound services that continue to outperform on quality and cost. Second, we are committed to margin recovery in value-based care. We've aligned our 2026 benefits and product portfolio and footprint with our payer partners to address the final year of V28 headwinds. We plan to cease arrangements for about two hundred thousand patients largely and fully accountable of the PPO patients we serve today. We expect to keep narrowing our exposure beyond 2026. We are increasing rates to reflect the higher risk profiles and acuity we are seeing and expect to continue. We believe the combination of these activities will mitigate about half the remaining $4 billion V28 headwind in 2026. The remainder of our offset will come from operating cost discipline, and consistent execution of our care programs, which enhance engagement, diagnosis accuracy, and quality outcomes, and reduce overall cost of care. With 2026 being the final year of V28 phase in, you should expect 2026 value-based care margins to remain relatively consistent with the one percent margin we are achieving this year. And then begin to advance again in 2027 and beyond. We are optimizing our portfolio of clinical practices. We are managing our fee for service and fully accountable risk”